Related Experiment Video
Updated: Apr 28, 2026

A 1.5 Hour Procedure for Identification of Enterococcus Species Directly from Blood Cultures
Published on: February 11, 2011
Clinical streptococci and their sensitivity to enterocins produced by different strains of the species Enterococcus
Anna Kandricáková1, Andrea Lauková
1Slovak Academy of Sciences, Institute of Animal Physiology, Košice, Slovakia.
Abstract:
In children, acute otitis media (AOM) is one of the most frequently occurring infections caused by Streptococcus pneumoniae and Str. pyogenes. The standard treatment of AOMis provided by antibiotics; however, an increased resistance of the causative agents to antibiotics requires the need to search for innovations. This study was focused on in vitro testing sensitivity of streptococci isolated from AOM to enterocins produced by 9 different origin strains of E. faecium. Enterocins (Ent) represent ribosomally synthesized proteinaceous substances with antimicrobial activity against Gram-positive and/or Gram-negative bacteria which are produced mostly by strains of the species Enterococcus faecium. Str. pneumoniae were sensitive at least to 1 Ent. Str. pneumoniae SPn 754 was sensitive to 5 Ent. Five Str. pyogenes were sensitive to enterocins. Ent A (P) inhibited the growth of 3 Str. pneumoniae, and 4 Str. pyogenes (activity between 100 and 3,200 AU/ml). Most of Ent inhibited the growth of streptococci tested (100-3,200 AU/ml). Str. pyogenes were more sensitive to Ent than Str. pneumoniae. Although more detailed further studies are required, our results indicate a new possibility for enterocin use.
Insights
This study explored enterocins (Ent) as a novel treatment for acute otitis media (AOM) in children. Enterocins showed antimicrobial activity against Streptococcus pneumoniae and Streptococcus pyogenes, suggesting a potential alternative to antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Acute otitis media (AOM) is a common childhood infection caused by Streptococcus pneumoniae and Streptococcus pyogenes.
- Antibiotic resistance in these pathogens necessitates the development of alternative treatments for AOM.
Purpose of the Study:
- To investigate the in vitro sensitivity of Streptococcus pneumoniae and Streptococcus pyogenes isolated from AOM to enterocins.
- To evaluate enterocins as a potential therapeutic agent against AOM-causing bacteria.
Main Methods:
- In vitro testing of streptococci isolated from AOM against enterocins produced by Enterococcus faecium strains.
- Determination of bacterial sensitivity and inhibition zones for various enterocins.
Main Results:
- Streptococcus pneumoniae strains showed sensitivity to at least one enterocin, with one strain sensitive to five.
- Streptococcus pyogenes strains demonstrated sensitivity to enterocins, with some inhibited by Enterocin A (P).
- Most enterocins inhibited the growth of tested streptococci at concentrations between 100 and 3,200 AU/ml, with Streptococcus pyogenes being more sensitive than Streptococcus pneumoniae.
Conclusions:
- Enterocins exhibit antimicrobial activity against key AOM pathogens, Streptococcus pneumoniae and Streptococcus pyogenes.
- Enterocins represent a promising alternative or adjunct therapy for AOM, warranting further investigation.
- The findings suggest a novel application for enterocins in combating antibiotic-resistant bacterial infections.
More Related Videos
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Stringent Response in E. coli
Staphylococcal Skin Infections
Bacterial Gastroenteritis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance